demonstrated that transcript levels of CIS were significantly elevated in SLE patients exhibiting active disease compared to both healthy controls and SLE patients with inactive disease, suggesting that CIS may serve as a potential biomarker for SLE and contribute to its pathogenesis (69). The gene discussed is CISH; the disease is systemic lupus erythematosus.